Nutex Health Inc. (NUTX)
- Previous Close
173.76 - Open
177.41 - Bid 172.22 x 100
- Ask 177.58 x 100
- Day's Range
155.01 - 177.50 - 52 Week Range
4.16 - 182.00 - Volume
213,950 - Avg. Volume
106,658 - Market Cap (intraday)
972.38M - Beta (5Y Monthly) --
- PE Ratio (TTM)
17.99 - EPS (TTM)
9.71 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
206.67
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations through its Management Services Organization (MSO) that provides management, administrative, and other support services to its affiliated hospitals and physician groups; and offers a cloud-based platform for healthcare organizations. The Real Estate segment owns and leases land and hospital buildings. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments that offer 24/7 care. In addition, the company provides healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; onsite inpatient pharmacies; emergency services; and in-patient services. The company was founded in 2011 and is headquartered in Houston, Texas.
www.nutexhealth.com800
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NUTX
View MorePerformance Overview: NUTX
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUTX
View MoreValuation Measures
Market Cap
967.15M
Enterprise Value
1.26B
Trailing P/E
17.90
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.95
Price/Book (mrq)
6.61
Enterprise Value/Revenue
2.63
Enterprise Value/EBITDA
8.50
Financial Highlights
Profitability and Income Statement
Profit Margin
10.76%
Return on Assets (ttm)
22.34%
Return on Equity (ttm)
78.92%
Revenue (ttm)
624.28M
Net Income Avi to Common (ttm)
67.18M
Diluted EPS (ttm)
9.71
Balance Sheet and Cash Flow
Total Cash (mrq)
87.67M
Total Debt/Equity (mrq)
124.19%
Levered Free Cash Flow (ttm)
49.05M